(Q44600979)

4 December 2017

Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema (English)

1 reference

4 December 2017

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(03)00266-6

15 March 2024

2

Harry W Flynn

1 reference

4 December 2017

1

Ingrid U Scott

1 reference

4 December 2017

3

Philip J Rosenfeld

1 reference

PubMed ID

14516818

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

PubMed ID

14516818

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0002939403002666?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0002-9394(03)00266-6

https://api.elsevier.com/content/article/PII:S0002939403002666?httpAccept=text/plain

15 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0002-9394(03)00266-6

American Journal of Ophthalmology

15 March 2024

published in

1 reference

4 December 2017

136

1 reference

4 December 2017

4

1 reference

4 December 2017

737-739

1 reference

Intravitreal triamcinolone for refractory diabetic macular edema

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900266-6

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900266-6

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900266-6

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900266-6

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

14516818